Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Experimental cancer drugs
Dibrospidium chloride
Другие языки:

Dibrospidium chloride

Подписчиков: 0, рейтинг: 0
Dibrospidium chloride
INN: Dibrospidium chloride
Spirobromin.svg
Clinical data
Other names Spirobromin, spirobromine
ATC code
Identifiers
  • 3,12-Bis(3-bromopropanoyl)-3,6,9,12-tetraazadispiro[5.2.5~9~.2~6~]hexadecane-6,9-diium dichloride
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C18-H32-Br2-N4-O2.2Cl
Molar mass 567.191
3D model (JSmol)
  • [Cl-].[Cl-].BrCCC(=O)N1CC[N+]2(CC1)CC[N+]3(CCN(CC3)C(=O)CCBr)CC2
  • InChI=InChI=1S/C18H32Br2N4O2.2ClH/c19-3-1-17(25)21-5-9-23(10-6-21)13-15-24(16-14-23)11-7-22(8-12-24)18(26)2-4-20;;/h1-16H2;2*1H/q+2;;/p-2
  • Key:CURYRIVJTBNEGU-UHFFFAOYSA-L

Dibrospidium chloride, also known as spirobromin, is a drug being investigated to treat bone cancer. It has potential anti-inflammatory and anti-neoplastic properties. It is an alkylating antineoplastic agent.

Dibrospidium chloride and related compounds were developed in Russia in the 1980s. It is currently used in Russia as a cytostatic antitumor chemotherapeutic drug.


Новое сообщение